Webinars
MDoutlook® Delivers Precision Intelligence
Upcoming Webinar:
Unlocking the Power of Pulse Research
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
November 18, 2021
Previous Webinars:
No post found
Our President and Founder, Jan Heybroek, was invited by PM360 to comment on recent concerns about the quality of (oncology) market research. The need to quickly track new product performance in priority markets is a key driver for this anxiety. This is relevant since standard prescription data, multi-disciplinary patient management,
Read more
In the 3rd quarter of 2017, MDOutlook undertook a global Thought Leader (TL) identification and ranking project in a rare cancer type. This activity used our standard approach with four domains - disease relevant publications, clinical trials, leadership roles (associations and journals), and peer nominations. We delivered detailed profiling of
Read more
“We attend ASCO regularly and never knew we could get help in ensuring the presented clinical data was optimally received by oncologists or how competitive announcements could potentially have an adverse impact. MDOutlook gave us new insights into projected usage rates of our therapy and helped us recalibrate our market
Read more
Are you getting the most out of industry events? MDOutlook leverages its client-acclaimed oncology insights and intelligence to drive our clients' commercialization success. We work with our clients to understand the impact of data announcements made at global conferences and assess the awareness and impact of these announcements on treatment
Read more
Here's what our clients are saying about their completed projects: “The MDOutlook team provided a succinct, clear, and targeted assessment of what we needed to support the commercial success of our oncology portfolio now and over the long term.” Director, Epidemiology Forecasting,Epidemiology & Advanced Analytics Large Biopharma Company “MDOutlook rocks!
Read more
In recent conversations with pharma companies and healthcare marketing agencies about their global market intelligence-gathering methods, MDOutlook has been hearing a rising concern about whether they are both reaching the right oncologists in the U.S. and other key countries and whether they are getting the right answers to the right
Read more
MDOutlook announces the launch of its latest syndicated research study in which U.S. and international oncologists provide their perspectives on who, why and how the industry demonstrates leadership in advancing cancer treatment and care. The Pharmaceutical Company Ranking in Oncology addresses and provides: what the oncologist community views as best
Read more
After every major conference, MDOutlook provides valuable insights to our clients on the impact of new data presented. With the 2017 ESMO conference here, we are planning a series of syndicated studies. Final disease focus will be updated following our analysts' review of new data presented. As an example of
Read more
At MDOutlook, we focus on providing actionable insights to our clients. These insights can provide valuable data to improve market share and compare and contrast our client's products to those of their competition. Below is a case study outlining the main reasons taxanes are not considered for use following paclitaxel
Read more
Whether it is the impact of the future usage in ALK positive lung cancer in first line of alectinib over the current standard of care or the potential use of DNA Disease repair in advanced BRCA-related breast cancer, many innovations in cancer treatment will be having an impact on the
Read more
Archives
[archives type=monthly limit=10]
Links
FDA Drug information:
http://www.fda.gov/Drugs
European Medicines Agency:
http://www.ema.europa.eu/
Publication Research:
http://www.ncbi.nlm.nih.gov/pubmed
Clinical Trials Research:
http://www.clinicaltrials.gov/